SEVERANCE and CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • August 3rd, 2017 • Sage Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Severance and Change in Control Agreement (this “Agreement”) is made as of March 21, 2017 by and between Sage Therapeutics, Inc., a Delaware corporation (the “Company”), and Michael Cloonan (the “Executive”) and shall become effective on the date of hire with the Company.
SIXTH AMENDMENT TO LEASELease • August 3rd, 2017 • Sage Therapeutics, Inc. • Pharmaceutical preparations
THIS SIXTH AMENDMENT TO LEASE (this “Sixth Amendment”) is made as of May 8, 2017, by and between ARE-MA REGION NO. 38, LLC, a Delaware limited liability company (“Landlord”), and SAGE THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
